Form D · Biotechnology
X-Biotix Therapeutics, Inc.
Waltham, MA · CIK 0001738806
Offering snapshot reported Nov 25, 2019 · SEC filing
- Reported sold
- $4.01M Offering amount: $4.01M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 12, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 25, 2019 | Initial | $4,009,994 | No comparison | 7 | SEC filing |
| Jun 25, 2019 | Amendment | $9,381,947 | $2,243,234vs Feb 13, 2019 | 7 | SEC filing |
| Feb 13, 2019 | Amendment | $7,138,713 | $1,000,002vs Apr 27, 2018 | 6 | SEC filing |
| Apr 27, 2018 | Initial | $6,138,711 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-354115
Source: Form D, filed Nov 25, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas G. Bernhardt Ph.D. | Executive |
| David Cook, Ph.D. | Director |
| Stephen T. Isaacs | Director |
| Christopher D. Ray | Director |
| Dominic Ryan | Executive |
| M. Dominic Ryan Ph.D. | Executive |
| Ramani Varanasi | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
465 Waverly Oaks Rd., Ste. 414
Waltham, MA, 02452
Waltham, MA, 02452